000 01082 a2200313 4500
005 20250514022841.0
264 0 _c20020307
008 200203s 0 0 eng d
022 _a0007-1161
024 7 _a10.1136/bjo.86.2.248
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBarampouti, F
245 0 0 _aShould active CMV retinitis in non-immunocompromised newborn babies be treated?
_h[electronic resource]
260 _bThe British journal of ophthalmology
_cFeb 2002
300 _a248-9 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aCytomegalovirus Retinitis
_xcongenital
650 0 4 _aFollow-Up Studies
650 0 4 _aGanciclovir
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunocompetence
650 0 4 _aInfant, Newborn
650 0 4 _aMale
700 1 _aRajan, M
700 1 _aAclimandos, W
773 0 _tThe British journal of ophthalmology
_gvol. 86
_gno. 2
_gp. 248-9
856 4 0 _uhttps://doi.org/10.1136/bjo.86.2.248
_zAvailable from publisher's website
999 _c11725294
_d11725294